Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients.

Mohamad Jarrah, Ayman J Hammoudeh, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Osama Okkeh, Imad A Alhaddad, Loai Issa Tawalbeh, Issa M Hweidi
Author Information
  1. Mohamad Jarrah: 1 Cardiology Section, Internal Medicine Department, King Abdullah University Hospital, Irbid, Jordan.
  2. Ayman J Hammoudeh: 2 Cardiology Department, Istishari Hospital, Amman, Jordan.
  3. Yousef Khader: 3 Allied Medical Sciences School, 37251 Jordan University of Science and Technology , Irbid, Jordan.
  4. Ramzi Tabbalat: 4 Cardiology Department, Khalidi Medical Center, Amman, Jordan.
  5. Eyas Al-Mousa: 2 Cardiology Department, Istishari Hospital, Amman, Jordan.
  6. Osama Okkeh: 5 Cardiology Department, Arab Medical Center, Amman, Jordan.
  7. Imad A Alhaddad: 6 Cardiology Department, Jordan Hospital Medical Center, Amman, Jordan.
  8. Loai Issa Tawalbeh: 7 Faculty of Nursing, Al AlBayt University, Almafraq, Jordan.
  9. Issa M Hweidi: 8 Faculty of Nursing, 37251 Jordan University of Science and Technology , Irbid, Jordan.

Abstract

Objective The aim of this study was to assess the baseline clinical characteristics, coronary angiographic features, and adverse cardiovascular events during hospitalization and at 1 year of follow-up in obese patients compared with overweight and normal/underweight patients. Methods A prospective, multicenter study of consecutive patients undergoing percutaneous coronary intervention was performed. Results Of 2425 enrolled patients, 699 (28.8%) were obese, 1178 (48.6%) were overweight, and 548 (22.6%) were normal/underweight. Obese patients were more likely to be female and to have a higher prevalence of diabetes, hypertension, hypercholesterolemia, or previous percutaneous coronary intervention. Acute coronary syndrome was the indication for percutaneous coronary intervention in 77.0% of obese, 76.4% of overweight, and 77.4% of normal/underweight patients. No significant differences in the prevalence of multi-vessel coronary artery disease or multi-vessel percutaneous coronary intervention were found among the three groups. Additionally, no significant differences were found in stent thrombosis, readmission bleeding rates, or cardiac mortality among the three groups during hospitalization, at 1 month, and at 1 year. Conclusion The major adverse cardiovascular event rate was the same among the three groups throughout the study period. Accordingly, body mass index is considered a weak risk factor for cardiovascular comorbidities in Arab Jordanian patients.

Keywords

References

  1. Circulation. 2015 Aug 4;132(5):457-72 [PMID: 26149446]
  2. Bratisl Lek Listy. 2011;112(7):402-6 [PMID: 21744737]
  3. Circulation. 2014 Dec 9;130(24):2143-51 [PMID: 25378546]
  4. Eur J Epidemiol. 2014 Nov;29(11):801-12 [PMID: 25354991]
  5. JAMA. 2012 Aug 8;308(6):619-20 [PMID: 22871873]
  6. Am J Cardiol. 2007 Nov 1;100(9):1331-5 [PMID: 17950785]
  7. Semin Dial. 2007 Nov-Dec;20(6):486-92 [PMID: 17991192]
  8. BMC Cardiovasc Disord. 2012 Aug 16;12:64 [PMID: 22894647]
  9. Am J Med. 2009 Dec;122(12):1106-14 [PMID: 19682667]
  10. Circulation. 2014 Dec 9;130(24):2131-2 [PMID: 25378545]
  11. Diabetol Int. 2016 May 3;8(1):30-38 [PMID: 30603304]
  12. Am J Cardiol. 2015 May 15;115(10):1428-34 [PMID: 25772740]
  13. Int J Obes (Lond). 2016 Feb;40(2):220-8 [PMID: 26338077]
  14. Circulation. 2006 Feb 14;113(6):898-918 [PMID: 16380542]
  15. JAMA. 2013 Jan 2;309(1):71-82 [PMID: 23280227]
  16. Chest. 2008 Nov;134(5):925-930 [PMID: 18641109]
  17. Lancet. 2015 Aug 22;386(9995):743-800 [PMID: 26063472]
  18. J Am Coll Cardiol. 2001 Sep;38(3):789-95 [PMID: 11527635]
  19. Eur Heart J. 2005 Jun;26(12):1169-79 [PMID: 15802360]
  20. Diabetes Care. 2011 Jan;34(1):210-5 [PMID: 20937689]
  21. Clin Geriatr Med. 2008 Aug;24(3):455-69, vi [PMID: 18672182]
  22. Obesity (Silver Spring). 2013 Sep;21(9):1746-9 [PMID: 24078231]
  23. Heart Lung Circ. 2018 Jul;27(7):785-791 [PMID: 29428203]
  24. Eur Heart J. 2010 Jan;31(2):146-8 [PMID: 19734553]
  25. Circulation. 2007 May 1;115(17):2344-51 [PMID: 17470709]
  26. Kidney Res Clin Pract. 2017 Mar;36(1):1-2 [PMID: 28428930]
  27. Int J Obes (Lond). 2012 Sep;36(9):1170-5 [PMID: 21946706]
  28. BMJ. 2013 Oct 01;347:f5446 [PMID: 24473060]
  29. Ann Saudi Med. 2014 Jan-Feb;34(1):38-45 [PMID: 24658552]
  30. Am J Cardiol. 2014 Jul 1;114(1):9-16 [PMID: 24846807]
  31. Diabetes Care. 1994 Sep;17(9):961-9 [PMID: 7988316]
  32. Pragmat Obs Res. 2017 Sep 21;8:183-187 [PMID: 29033626]
  33. Circ Cardiovasc Interv. 2014 Dec 31;8(1): [PMID: 25552564]
  34. Ann Saudi Med. 2016 Jan-Feb;36(1):17-22 [PMID: 26922683]
  35. Ann Intern Med. 1995 Apr 1;122(7):481-6 [PMID: 7872581]
  36. J Am Coll Cardiol. 2013 Aug 20;62(8):685-91 [PMID: 23948512]
  37. Int J Cardiol. 2013 Aug 20;167(4):1154-8 [PMID: 22475846]
  38. Stroke. 2011 Jan;42(1):30-6 [PMID: 21127299]
  39. N Engl J Med. 2014 Apr 3;370(14):1363-4 [PMID: 24693908]
  40. Circulation. 2009 Apr 14;119(14):1873-82 [PMID: 19332461]

MeSH Term

Body Mass Index
Coronary Angiography
Coronary Artery Disease
Hospitalization
Humans
Middle East
Obesity
Percutaneous Coronary Intervention

Word Cloud

Created with Highcharts 10.0.0coronarypatientspercutaneousinterventioncardiovascularstudyadverse1obeseoverweightnormal/underweightamongthreegroupsobesityeventshospitalizationyearResults6%prevalence774%significantdifferencesmulti-vesseldiseasefoundmajorMiddleEasternObjectiveaimassessbaselineclinicalcharacteristicsangiographicfeaturesfollow-upcomparedMethodsprospectivemulticenterconsecutiveundergoingperformed2425enrolled699288%11784854822ObeselikelyfemalehigherdiabeteshypertensionhypercholesterolemiapreviousAcutesyndromeindication0%76arteryAdditionallystentthrombosisreadmissionbleedingratescardiacmortalitymonthConclusioneventratethroughoutperiodAccordinglybodymassindexconsideredweakriskfactorcomorbiditiesArabJordanianRealityparadox:Cardiovascularparadox

Similar Articles

Cited By